GGrantIndex
Sort

27,075 grants matching cholesterol

Glia Exclusive Gene Therapy

$238,500
Or Shemesh · University Of Pittsburgh At Pittsburgh · R21 · FY2023 · EB

REGULATION OF MYOMETRIAL RELAXATION: AGONIST-SPECIFIC cGMP ACTION

$238,493
Iain L Buxton · University Of Nevada Reno · R01 · FY2011 · HD

BENZODIAZEPINE RECEPTOR AND ADRENAL DEVELOPMENT

$238,392
Boston University · R01 · FY2000 · DK

Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents

$238,369
Juan Enrique Rozengurt · University Of California Los Angeles · P01 · FY2022 · CA

Plasma membrane cholesterol & monocyte /macrophage funct

$238,307
Frederick R. Maxfield · Weill Medical Coll Of Cornell Univ · P01 · FY2006 · HL

SQLE and Sterols Contribute to Racial Disparity in ER+ Breast Cancer Patient Survival

$238,200
Jonna Frasor · University Of Illinois At Chicago · R21 · FY2023 · CA

Discovery of New Anti-amoeba Therapeutics

$238,147
William David Nes · Texas Tech University · R21 · FY2016 · AI

Overcoming gene delivery barriers to the back of the eye

$238,145
Gaurav Sahay · Oregon State University · R21 · FY2020 · EY

Role of Benzodiazepine Receptor in Leydig Cell Function

$238,140
Vassilios Papadopoulos · Mcgill University Health Ctr Res Inst · R01 · FY2009 · ES

Role of Benzodiazepine Receptor in Leydig Cell Function

$238,140
Vassilios Papadopoulos · Mcgill University Health Ctr Res Inst · R01 · FY2008 · ES

Relationship of Blood Esterases, Pesticide Exposure and Cardiovascular Disease

$238,134
Janice E. Chambers · Mississippi State University · R21 · FY2008 · ES

STANDARDIZATION OF BOTANICAL DIETARY SUPPLEMENT FOR WOMEN'S HEALTH

$238,131
Norman R Farnsworth · University Of Illinois At Chicago · P50 · FY2008 · AT

PROTEIN LIPID INTERACTIONS IN GALLSTONE PATHOGENESIS

$238,112
Beth Israel Deaconess Medical Center · R01 · FY2001 · DK

HUMAN BIOMARKER DISCOVERY AND VALIDATION STUDIES

$238,109
Joel G Pounds · Battelle Pacific Northwest Laboratories · U54 · FY2008 · ES

Relapse Prevention: Long-Acting Atypical Antipsychotics

$238,108
Del D Miller · University Of Iowa · U01 · FY2008 · MH

Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents

$238,095
Juan Enrique Rozengurt · University Of California Los Angeles · P01 · FY2023 · CA

EFFECT OF LDL CHOLESTEROL LOWERING BEYOND CURRENTLY RECOMMENDED MINIM

$237,978
La Biomed Res Inst/ Harbor Ucla Med Ctr · M01 · FY2001 · RR

ATORVA 54 OPEN LABEL ASSESSMENT

$237,978
La Biomed Res Inst/ Harbor Ucla Med Ctr · M01 · FY2001 · RR

Morphology Core

$237,965
Thomas A Drake · University Of California Los Angeles · P01 · FY2009 · HL

Morphology Core

$237,965
Thomas A Drake · University Of California Los Angeles · P01 · FY2010 · HL

Morphology Core

$237,965
Thomas A Drake · University Of California Los Angeles · P01 · FY2012 · HL

Morphology Core

$237,965
Thomas A Drake · University Of California Los Angeles · P01 · FY2011 · HL

Characterization of the role of ARH on LDLR function

$237,938
Peter A Michaely · Ut Southwestern Medical Center · R01 · FY2012 · HL

DIET, IMMUNODEFICIENCY-VIRUS INFECTION, AND CARDIOVASCULAR RISK

$237,907
Bela F Asztalos · Harvard Medical School · P51 · FY2008 · RR

Developing techniques to generate the first transgenic opossums

$237,900
Karen E Sears · University Of Illinois At Urbana-Champaign · R21 · FY2016 · OD